Cited by 727Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease

Open access
Streit, Wolfgang J., Braak, Heiko, Xue, Qing-Shan, Bechmann, Ingo·2009·Acta Neuropathologica

Abstract

The role of microglial cells in the pathogenesis of Alzheimer's disease (AD) neurodegeneration is unknown. Although several works suggest that chronic neuroinflammation caused by activated microglia contributes to neurofibrillary degeneration, anti-inflammatory drugs do not prevent or reverse neuronal tau pathology. This raises the question if indeed microglial activation occurs in the human brain at sites of neurofibrillary degeneration. In view of the recent work demonstrating presence of dystrophic (senescent) microglia in aged human brain, the purpose of this study was to investigate microglial cells in situ and at high resolution in the immediate vicinity of tau-positive structures in order to determine conclusively whether degenerating neuronal structures are associated with activated or with dystrophic microglia. We used a newly optimized immunohistochemical method for visualizing microglial cells in human archival brain together with Braak staging of neurofibrillary pathology to ascertain the morphology of microglia in the vicinity of tau-positive structures. We now report histopathological findings from 19 humans covering the spectrum from none to severe AD pathology, including patients with Down's syndrome, showing that degenerating neuronal structures positive for tau (neuropil threads, neurofibrillary tangles, neuritic plaques) are invariably colocalized with severely dystrophic (fragmented) rather than with activated microglial cells. Using Braak staging of Alzheimer neuropathology we demonstrate that microglial dystrophy precedes the spread of tau pathology. Deposits of amyloid-beta protein (Abeta) devoid of tau-positive structures were found to be colocalized with non-activated, ramified microglia, suggesting that Abeta does not trigger microglial activation. Our findings also indicate that when microglial activation does occur in the absence of an identifiable acute central nervous system insult, it is likely to be the result of systemic infectious disease. The findings reported here strongly argue against the hypothesis that neuroinflammatory changes contribute to AD dementia. Instead, they offer an alternative hypothesis of AD pathogenesis that takes into consideration: (1) the notion that microglia are neuron-supporting cells and neuroprotective; (2) the fact that development of non-familial, sporadic AD is inextricably linked to aging. They support the idea that progressive, aging-related microglial degeneration and loss of microglial neuroprotection rather than induction of microglial activation contributes to the onset of sporadic Alzheimer's disease. The results have far-reaching implications in terms of reevaluating current treatment approaches towards AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-009-0556-6

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Iba1 is a pan-microglial marker whose expression increases with microglial activation.

    “Iba1 is a pan-microglial marker whose expression increases with microglial activation,58, 77”

    From Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review (2018) · cites this paper as [77]

    The Results (Fig. 1; page unavailable) say anti-Iba1 labeled the entire microglial population, supporting its use as a pan-microglial marker. The Results and Discussion distinguish activated cells by hypertrophy and morphology, but do not say that Iba1 expression increases with activation. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Dystrophic microglia, much more than activated microglia, are present in human Alzheimer's disease.

    “In fact, we have shown that dystrophic, much more than activated microglia are present in human AD [83,104,107].”
  • Studies using cell counting for Iba1 assess the absolute number of microglia in the samples.

    “In contrast, the studies using cell counting for Iba1, which is expressed by all microglia,58, 77 assess the absolute number of microglia in the samples.”
  • With ageing, microglial cells exhibit dystrophic changes, which are thought to be distinct from their typical reactive morphology.

    “With ageing, microglial cells exhibit dystrophic changes, which are thought to be distinct from their typical reactive morphology.”

    From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [157]

  • Neuropathological features of AD are associated with dystrophic microglial cells that exhibit morphological changes indicative of senescence.

    “neuropathological features of AD have been associated with dystrophic microglial cells that exhibit morphological changes indicative of senescence [157].”

    From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [157]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [3]Boche D Nicoll JA The role of the immune system in clearance of Abeta from the brain Brain Pathol 2008 18 267 278 10.1111/j.1750-3639.2008.00134.x PMC8095633 18363937 Boche D, Nicoll JA (2008) The role of the immune system in clearance of Abeta from the brain. Brain Pathol 18:267–278 18363937 PMC8095633 · DOI

Cited by

Sorted by citations

Authors
Streit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I.
Affiliations
  • University of Florida Health (US)
  • Universität Ulm (DE)
  • University Hospital Frankfurt (DE)
Corresponding author
Streit, Wolfgang J.
Venue
Acta Neuropathologica
Published
2009-06-10
Volume
118
Issue
4
Pages
475-485
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2072210142
Cited by
727
References
47
Citations by year
2026: 29 · 2025: 38 · 2024: 67 · 2023: 49 · 2022: 58 · 2021: 70 · 2020: 64 · 2019: 50 · 2018: 49 · 2017: 33 · 2016: 34 · 2015: 38 · 2014: 31 · 2013: 35 · 2012: 25
FWCI
17.52
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Acta Neuropathologica (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by-nc)
Funders
  • Deutsche Forschungsgemeinschaft
  • National Institutes of Health
  • National Institute on Aging (R01AG023665, AG 023665)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
Alzheimer's disease, microglial activation, tau pathology, neurofibrillary degeneration, neuroinflammation, amyloid-beta, Braak staging, Down syndrome, sporadic Alzheimer's disease, neuroprotection, aging, neurodegeneration, neuropil threads, neuritic plaques, systemic infection, microglial morphology
MeSH terms
Adult, Aged, Aged, 80 and over, Aging, Alzheimer Disease, Cerebral Cortex, Down Syndrome, Female, Humans, Immunohistochemistry, Male, Middle Aged, Nerve Degeneration, Neurofibrillary Tangles, tau Proteins, Microglia, Neuropil Threads

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review